Wealthspire Advisors, LLC Electro Core, Inc. Transaction History

Wealthspire Advisors, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 09, 2022	BUY	$0.27 - $0.61 $54,000 - $122,000	200,000 Added 40.0%	700,000 $357,000
Q1 2022 May 09, 2022	BUY	$0.5 - $0.88 $250,000 - $440,000	500,000 New	500,000 $293,000
Q4 2021 Feb 14, 2022	SELL	$0.58 - $1.09 $174,015 - $327,028	-300,026 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$1.19 - $2.06 $119,000 - $206,000	100,000 Added 49.99%	300,026 $357,000
Q4 2020 Feb 16, 2021	BUY	$1.44 - $1.98 $288,037 - $396,051	200,026 New	200,026 $312,000
Q2 2020 Aug 14, 2020	SELL	$0.75 - $1.29 $75,019 - $129,033	-100,026 Closed	0 $0
Q1 2020 May 12, 2020	BUY	$0.33 - $1.62 $33,008 - $162,042	100,026 New	100,026 $95,000

143K

Ticker ECOR
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 71,176,896
Market Cap $1.09B
Description
electroCore, Inc., a commercial stage medical device company, engages in the development and commercialization of a range of non-invasive vagus nerve stimulation (nVNS) therapies. The company is developing gammaCore, a prescription-only nVNS therapy for the acute treatment of pain associated with migraine and episodic cluster headache in adults....

Get notified when there are updates to the investment portfolio of Wealthspire Advisors, LLC, based on Form 13F filings with the SEC.

Stay updated on Wealthspire Advisors, LLC with notifications on news.